Vitamin D levels and insulin resistance in children born with severe growth restriction

V I Giapros1, A S Challa, V L Cholevas

  • 1Neonatal Intensive Care Unit, University Hospital of Ioannina, 45110 Ioannina, Greece. vgiapros@cc.uoi.gr

Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|September 20, 2012
PubMed

Insights

Children born small-for-gestational-age (SGA) have higher vitamin D levels and altered insulin resistance and beta-cell function at prepuberty. These vitamin D levels may influence beta-cell function in growth-restricted children.

Area of Science:

  • Pediatric Endocrinology
  • Nutritional Biochemistry
  • Metabolic Health

Background:

  • Small-for-gestational-age (SGA) birth is linked to long-term metabolic risks.
  • Vitamin D status and its role in metabolic regulation are critical areas of research.

Purpose of the Study:

  • To investigate serum 25(OH)D levels in prepubertal SGA versus appropriate-for-gestational-age (AGA) children.
  • To correlate 25(OH)D levels with birth weight, insulin resistance (HOMA-IR), and beta-cell function (HOMA-β%).

Main Methods:

  • Cross-sectional study of 65 nonobese children (5-7.5 years old).
  • Measurement of serum 25(OH)D, PTH, glucose, and insulin.
  • Calculation of HOMA-IR and HOMA-β% indices.

Main Results:

  • SGA children exhibited significantly higher mean 25(OH)D levels (26.2 vs. 17.2 ng/ml).
  • SGA group showed increased HOMA-IR and HOMA-β% compared to AGA.
  • In SGA children, 25(OH)D correlated with HOMA-β%, not HOMA-IR.
  • Total cohort: 25(OH)D and HOMA-IR negatively correlated with birth weight.

Conclusions:

  • Prepubertal children born SGA have elevated, birth weight-dependent 25(OH)D levels.
  • Increased 25(OH)D in SGA children may play a regulatory role in beta-cell function.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...